Farrelly D, Brown K S, Tieman A, Ren J, Lira S A, Hagan D, Gregg R, Mookhtiar K A, Hariharan N
Bristol-Myers Squibb Pharmaceutical Research Institute, Metabolic Diseases, Princeton, NJ 08540-4000, USA.
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14511-6. doi: 10.1073/pnas.96.25.14511.
The importance of glucokinase (GK; EC 2.7.1.12) in glucose homeostasis has been demonstrated by the association of GK mutations with diabetes mellitus in humans and by alterations in glucose metabolism in transgenic and gene knockout mice. Liver GK activity in humans and rodents is allosterically inhibited by GK regulatory protein (GKRP). To further understand the role of GKRP in GK regulation, the mouse GKRP gene was inactivated. With the knockout of the GKRP gene, there was a parallel loss of GK protein and activity in mutant mouse liver. The loss was primarily because of posttranscriptional regulation of GK, indicating a positive regulatory role for GKRP in maintaining GK levels and activity. As in rat hepatocytes, both GK and GKRP were localized in the nuclei of mouse hepatocytes cultured in low-glucose-containing medium. In the presence of fructose or high concentrations of glucose, conditions known to relieve GK inhibition by GKRP in vitro, only GK was translocated into the cytoplasm. In the GKRP-mutant hepatocytes, GK was not found in the nucleus under any tested conditions. We propose that GKRP functions as an anchor to sequester and inhibit GK in the hepatocyte nucleus, where it is protected from degradation. This ensures that glucose phosphorylation is minimal when the liver is in the fasting, glucose-producing phase. This also enables the hepatocytes to rapidly mobilize GK into the cytoplasm to phosphorylate and store or metabolize glucose after the ingestion of dietary glucose. In GKRP-mutant mice, the disruption of this regulation and the subsequent decrease in GK activity leads to altered glucose metabolism and impaired glycemic control.
葡萄糖激酶(GK;EC 2.7.1.12)在葡萄糖稳态中的重要性已通过人类中GK突变与糖尿病的关联以及转基因和基因敲除小鼠葡萄糖代谢的改变得到证实。人类和啮齿动物肝脏中的GK活性受到GK调节蛋白(GKRP)的变构抑制。为了进一步了解GKRP在GK调节中的作用,小鼠GKRP基因被灭活。随着GKRP基因的敲除,突变小鼠肝脏中GK蛋白和活性同时丧失。这种丧失主要是由于GK的转录后调节,表明GKRP在维持GK水平和活性方面具有正向调节作用。与大鼠肝细胞一样,在含低葡萄糖的培养基中培养的小鼠肝细胞中,GK和GKRP都定位于细胞核。在果糖或高浓度葡萄糖存在的情况下,已知这些条件在体外可解除GKRP对GK的抑制,此时只有GK转运到细胞质中。在GKRP突变的肝细胞中,在任何测试条件下细胞核中都未发现GK。我们提出,GKRP作为一种锚定物,在肝细胞核中隔离并抑制GK,使其免受降解。这确保了肝脏处于空腹、产生葡萄糖阶段时葡萄糖磷酸化降至最低。这也使肝细胞能够在摄入膳食葡萄糖后迅速将GK转运到细胞质中,以磷酸化并储存或代谢葡萄糖。在GKRP突变小鼠中,这种调节的破坏以及随后GK活性的降低导致葡萄糖代谢改变和血糖控制受损。